These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17611413)

  • 41. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
    Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
    Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
    Reffas S; Schlegel W
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2.
    Ben-Levy R; Hooper S; Wilson R; Paterson HF; Marshall CJ
    Curr Biol; 1998 Sep; 8(19):1049-57. PubMed ID: 9768359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity.
    Camp HS; Tafuri SR; Leff T
    Endocrinology; 1999 Jan; 140(1):392-7. PubMed ID: 9886850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells.
    Ceni E; Crabb DW; Foschi M; Mello T; Tarocchi M; Patussi V; Moraldi L; Moretti R; Milani S; Surrenti C; Galli A
    Gastroenterology; 2006 Oct; 131(4):1235-52. PubMed ID: 17030193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
    Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
    Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
    J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export.
    Khateeb J; Kiyan Y; Aviram M; Tkachuk S; Dumler I; Fuhrman B
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):449-58. PubMed ID: 22155455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Transcription Factor IRF6 Co-Represses PPARγ-Mediated Cytoprotection in Ischemic Cerebrovascular Endothelial Cells.
    Huang R; Hu Z; Feng Y; Yu L; Li X
    Sci Rep; 2017 May; 7(1):2150. PubMed ID: 28526834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation.
    Bijli KM; Kleinhenz JM; Murphy TC; Kang BY; Adesina SE; Sutliff RL; Hart CM
    Free Radic Biol Med; 2015 Mar; 80():111-20. PubMed ID: 25557278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A.
    Olsen H; Haldosén LA
    Exp Cell Res; 2006 May; 312(8):1371-80. PubMed ID: 16457814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear ERK Translocation is Mediated by Protein Kinase CK2 and Accelerated by Autophosphorylation.
    Plotnikov A; Chuderland D; Karamansha Y; Livnah O; Seger R
    Cell Physiol Biochem; 2019; 53(2):366-387. PubMed ID: 31385665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth Muscle.
    Mukohda M; Lu KT; Guo DF; Wu J; Keen HL; Liu X; Ketsawatsomkron P; Stump M; Rahmouni K; Quelle FW; Sigmund CD
    Hypertension; 2017 Jul; 70(1):174-182. PubMed ID: 28507170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M; Lee TW; Yim AP; Mok TS; Chen GG
    J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
    Han S; Sidell N; Fisher PB; Roman J
    Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase.
    Fukuda M; Gotoh Y; Nishida E
    EMBO J; 1997 Apr; 16(8):1901-8. PubMed ID: 9155016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
    Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
    Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peroxisome proliferator-activated receptor gamma as a novel target in cancer therapy: binding and activation by an aromatic fatty acid with clinical antitumor activity.
    Samid D; Wells M; Greene ME; Shen W; Palmer CN; Thibault A
    Clin Cancer Res; 2000 Mar; 6(3):933-41. PubMed ID: 10741718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.